Check out our latest webinar, “Safety and Feasibility of a Compensated Donor Model”. Click here to watch!

Email Sent Successfully!

We usually respond within 24 hours.
If you need immediate help, please give us a call at
(855) 944-3787.

STS presented data demonstrating initial feasibility and safety of its platelet donation model. Click here to see the poster presentation developed for the 2022 AABB Annual Meeting.

Follow us on LinkedIn

Scroll to Top

Federal mandates may constrain platelet availability even more4

The safety of platelet transfusions is critical, and the recent US Food and Drug Administration (FDA) mandate requires bacterial risk mitigation strategies such as large volume delayed sampling or pathogen reduction. Processing requirements associated with these bacterial risk mitigation strategies may further erode the platelet supply.

Secure Transfusion Services Icon